Edris Badreddin's Form 4 filing
SpringWorks Therapeutics, Inc. (SWTX) · filed Mar 5, 2025
- Accession no.
- 0001104659-25-021008
- Filed
- Mar 5, 2025
- Trade date
- Mar 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.08M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edris BadreddinCIK 0001786966 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | SSaleDisposed | −3,924 | $53.12 | −$208,442.88 | 185,788 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −12,078 | $54.26 | −$655,352.28 | 173,710 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −3,598 | $55.12 | −$198,321.76 | 170,112 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −400 | $56.20 | −$22,480 | 169,712 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.